Thermo Fisher Scientific (TMO) total debt

Total debt · fiscal 2025
$39.39B

Thermo Fisher Scientific (TMO) carried total debt of $39.39B at the end of fiscal 2025 (December 31, 2025). That is 25.9% higher than the $31.28B of fiscal 2024. Figures as of 18 Nov 2026, 08:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$39.39B
Change on fiscal 2024
+25.9%
Growth, 5 years
+12.6% a year
Highest on record
$39.39Bfiscal 2025
Lowest on record
$17.75Bfiscal 2019
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Thermo Fisher Scientific total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 12.6% a year. Across the 8 fiscal years on record (2018–2025), the highest was $39.39B in fiscal 2025 and the lowest $17.75B in fiscal 2019.

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

History · 8 fiscal years

Total debt by fiscal year

Thermo Fisher Scientific total debt, year by year

Thermo Fisher Scientific (TMO) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$39.39B 25.9% up0.7×
2024$31.28B 10.4% down0.6×
2023$34.92B 1.2% up0.7×
2022$34.49B 7.3% down0.8×
2021$37.21B 71.2% up0.9×
2020$21.74B 22.4% up0.6×
2019$17.75B 9.8% down0.6×
2018$19.68B—0.7×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Thermo Fisher Scientific and comparable companies
CompanyTotal debtFiscal year
UnitedHealth Group UNH$78.39B2025
Novartis NVS$35.38B2025
AstraZeneca AZN$29.15B2025
Thermo Fisher Scientific TMO$39.39B2025
Amgen AMGN$54.60B2025
Gilead Sciences GILD$24.94B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TMO

Thermo Fisher Scientific, figure by figure

Thermo Fisher Scientific (TMO) overview: price, valuation and scorecardAll health care companies by market value

Thermo Fisher Scientific total debt: questions and answers

How much debt does Thermo Fisher Scientific have?

Thermo Fisher Scientific (TMO) carried total debt of $39.39B at the end of fiscal 2025 (December 31, 2025). That is 25.9% higher than the $31.28B of fiscal 2024.

What is the growth rate of Thermo Fisher Scientific's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 12.6% a year.

What are the highest and lowest total debt figures on record for Thermo Fisher Scientific?

Across the 8 fiscal years on record (2018–2025), the highest was $39.39B in fiscal 2025 and the lowest $17.75B in fiscal 2019.

How does Thermo Fisher Scientific's debt compare with its equity?

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

How is Thermo Fisher Scientific's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Thermo Fisher Scientific (TMO) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/TMO/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.